Search

AtriCure Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

58.13 -1.21

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

57.67

Max

59.79

Pagrindiniai rodikliai

By Trading Economics

Pajamos

8.8M

9M

Pardavimai

12M

154M

P/E

Sektoriaus vid.

265.667

56.432

Pelnas, tenkantis vienai akcijai

0.18

Pelno marža

5.83

Darbuotojai

1,350

EBITDA

-3.8M

3.2M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

-5.34% downside

Dividendai

By Acuity

Kitas uždarbis

2026-10-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.1B

2.8B

Ankstesnė atidarymo kaina

59.34

Ankstesnė uždarymo kaina

58.13

Naujienos nuotaikos

By Acuity

34%

66%

56 / 339 reitingas Healthcare

AtriCure Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-18 20:02; UTC

AtriCure Inc shares fell sharply, breaking a recent pattern of higher daily closes amid unusually high market volume.

2026-09-17 20:07; UTC

AtriCure Inc is advancing in today's trading session, continuing a trend that has seen the stock rise significantly since Wednesday's close.

2026-09-16 19:44; UTC

AtriCure Inc is trading higher, maintaining a price above its 20-day moving average and marking gains in four consecutive sessions.

2026-09-15 20:07; UTC

News

AtriCure Inc's stock is higher following an insider sale of 5,313 shares by Board Member Regina E. Groves for about $288,070.

2026-09-14 20:07; UTC

News

AtriCure reports gross revenue of $534.53 million and a net income loss of $11.45 million, with shares advancing amid positive market sentiment.

2026-09-11 22:11; UTC

AtriCure Inc. shares are lower in after-market trading, continuing a decline since Friday's close amid notably weak overall market conditions.

2026-09-09 20:07; UTC

AtriCure Inc. shares are lower today, following a notable drop at the open amid broader market volatility. No specific news was identified for the decline.

2026-09-08 20:01; UTC

News

AtriCure Inc. is trading higher as analysts issue mixed ratings and price targets, with BTIG raising its target to $55.00.

2026-09-03 20:01; UTC

AtriCure Inc shares are lower during Thursday's session, continuing a decline since Wednesday. No specific news was identified to explain the movement.

2026-09-02 20:01; UTC

News

AtriCure Inc shares are higher following an upgrade from Needham, raising the price target to $64.00 from $45.00 while maintaining a Buy rating.

2026-09-01 20:08; UTC

AtriCure Inc. shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains strong above its 20-day moving average.

2026-08-31 19:26; UTC

AtriCure Inc's shares are lower amid broader market sentiment influenced by interest rate concerns, despite remaining above their 20-day moving average.

2026-08-28 19:16; UTC

AtriCure Inc shares are lower today, following an early dip. Broader market concerns about inflation and growth expectations may be influencing sentiment.

2026-08-26 19:08; UTC

News

AtriCure Inc shares are lower amid Health Care Equipment sector weakness and an insider sale of 9,370 shares valued at $458,099.

2026-08-24 19:36; UTC

News

AtriCure's price target raised to $55 from $45 by BTIG. Shares are higher, reflecting positive sentiment on the company's growth prospects.

2026-08-20 19:46; UTC

AtriCure Inc shares are higher today, maintaining gains since Wednesday's close, despite earlier fluctuations. The stock remains above its 20-day moving average.

2026-08-19 20:01; UTC

AtriCure Inc shares are trading higher during Wednesday's session, continuing a strong upward trajectory since Tuesday's close, despite no specific news identified.

2026-08-18 19:16; UTC

AtriCure Inc shares are higher today, continuing momentum from Monday's close. Broader market factors include rising U.S. Treasury yields amid inflation concerns.

2026-08-17 22:46; UTC

AtriCure Inc is trading higher in after-market hours, with no specific news identified for the move. The stock remains above its 20-day moving average.

2026-08-12 20:06; UTC

AtriCure Inc shares are higher today, continuing a nine-session streak of gains. The stock remains above its 20-day moving average.

2026-08-11 22:41; UTC

AtriCure Inc shares are higher in after-market trading, continuing a recent trend of strength amid changing monetary policies from central banks.

2026-08-07 20:03; UTC

AtriCure Inc's shares are higher during Friday's session, continuing an upward trend since Thursday's close, and remain above their 20-day moving average.

2026-08-06 19:12; UTC

AtriCure Inc shares are higher, benefiting from an upward trend in the Health Care Equipment sub-sector. Earlier, the stock peaked before a slight pullback.

2026-08-05 19:51; UTC

AtriCure Inc shares are higher today, despite no specific news. Broader market sentiment is cautious following ADP's disappointing employment report.

2026-08-03 20:06; UTC

AtriCure Inc. shares are higher during Monday's session, regaining ground after an earlier pullback. Broader market trends support positive investor sentiment.

2026-07-31 20:03; UTC

News

AtriCure shares are lower amid significant insider selling, including a $233,280 sale by Chief Scientific Officer Vinayak Doraiswamy and options exercised by Board Member Sven Wehrwein.

2026-07-30 18:56; UTC

AtriCure Inc's shares are lower today, impacted by declines in the Health Care Equipment sub-sector. No specific company news was identified for the movement.

2026-07-29 20:03; UTC

News

AtriCure Inc shares reached a 52-week high of $43.18 following better-than-expected quarterly earnings, despite a pullback earlier in the session.

2026-07-28 19:21; UTC

AtriCure Inc's shares are higher today amid stronger gains in U.S. and European indices, with no specific company news identified for the movement.

2026-07-27 20:02; UTC

News

AtriCure Inc shares are higher as the company prepares for two investor conferences and highlights CEO Michael Carrel's leadership appointment.

Akcijų palyginimas

Kainos pokytis

AtriCure Inc Prognozė

Kainos tikslas

By TipRanks

-5.34% į apačią

12 mėnesių prognozė

Vidutinis 55 USD  -5.34%

Aukščiausias 65 USD

Žemiausias 36 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines AtriCure Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

8 ratings

6

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

56 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.